QR Kodea

Gliflozins in Practice: Real-Life Use of Dapagliflozin and Empagliflozin in HFrEF Versus Clinical Trial Data

<b>Background:</b> Sodium/glucose cotransporter-2 inhibitors (SGLT2is), such as dapagliflozin and empagliflozin, are currently a standard therapy for heart failure (HF) patients. We report the real-world use of SGLT2is in a monocentric cohort of HF patients with reduced ejection fraction (HFrEF) and...

Deskribapen osoa

Gorde:
Egile Nagusiak: Massimo Mapelli, Rebecca Caputo, Massimo Valenti, Filippo Maria Rubbo, Elisabetta Salvioni, Irene Mattavelli, Arianna Galotta, Arianna Piotti, Fiorella Puttini, Laura Manfrin, Carlo Vignati, Simona Costantino, Piergiuseppe Agostoni
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2026-03-01
Saila:Diagnostics
Gaiak:
heart failure
SGLT2i
dapagliflozin
empagliflozin
real-life
Sarrera elektronikoa:https://www.mdpi.com/2075-4418/16/5/769
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak